5.4

CVE-2025-43787

A Stored cross-site scripting vulnerability in the Liferay Portal  7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q3.0, 2025.Q2.0 through 2025.Q2.12, 2025.Q1.0 through 2025.Q1.17, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.0 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13 and 2024.Q1.1 through 2024.Q1.20 allows an remote authenticated attacker to inject JavaScript through the organization site names. The malicious payload is stored and executed without proper sanitization or escaping.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Liferay ≫ Digital Experience Platform Version >= 2024.q1.1 < 2024.q1.21
Liferay ≫ Digital Experience Platform Version >= 2024.q2.0 <= 2024.q2.13
Liferay ≫ Digital Experience Platform Version >= 2024.Q3.0 <= 2024.Q3.13
Liferay ≫ Digital Experience Platform Version >= 2024.q4.0 <= 2024.q4.7
Liferay ≫ Digital Experience Platform Version >= 2025.Q1.0 <= 2025.Q1.17
Liferay ≫ Digital Experience Platform Version >= 2025.q2.0 <= 2025.q2.12
Liferay ≫ Digital Experience Platform Version 2025.q3.0
Liferay ≫ Liferay Portal Version >= 7.4.0 <= 7.4.3.132
VulnDex Vulnerability Enrichment
Diese Information steht angemeldeten Benutzern zur Verfügung. Login Login
Zu dieser CVE wurde keine Warnung gefunden.
EPSS Metriken
Typ Quelle Score Percentile
EPSS FIRST.org 0.21% 0.116
CVSS Metriken
Quelle Base Score Exploit Score Impact Score Vector String
NIST 5.4 2.3 2.7
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
security@liferay.com 5.1 0 0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

https://liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/CVE-2025-43787
Vendor Advisory